HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey D Lifson Selected Research

6P4-RANTES

5/2009Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey D Lifson Research Topics

Disease

128Infections
01/2022 - 10/2002
45Viremia
01/2022 - 02/2003
29HIV Infections (HIV Infection)
01/2020 - 02/2003
27Acquired Immunodeficiency Syndrome (AIDS)
01/2022 - 12/2003
11Disease Progression
01/2018 - 01/2008
8Virus Diseases (Viral Diseases)
11/2020 - 11/2008
6Persistent Infection
12/2019 - 12/2013
4Coinfection
11/2014 - 04/2004
3Neoplasms (Cancer)
01/2022 - 01/2018
3Herpes Simplex
01/2018 - 02/2014
3Fibrosis (Cirrhosis)
03/2015 - 02/2007
2Communicable Diseases (Infectious Diseases)
11/2019 - 12/2018
2Neurocognitive Disorders (Clerambault Syndrome)
01/2018 - 01/2016
2Inflammation (Inflammations)
12/2015 - 03/2013
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2014 - 09/2012
1Vaccinia
11/2020
1Vesicular Stomatitis
11/2020
1Body Weight (Weight, Body)
10/2020
1Rubella (German Measles)
01/2020
1Papillomavirus Infections
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Tuberculosis (Tuberculoses)
01/2017
1Lentivirus Infections
01/2017

Drug/Important Bio-Agent (IBA)

45VaccinesIBA
01/2022 - 02/2003
17DNA (Deoxyribonucleic Acid)IBA
11/2020 - 10/2002
17Antiviral Agents (Antivirals)IBA
12/2019 - 09/2003
15Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2002
14RNA (Ribonucleic Acid)IBA
09/2021 - 03/2002
10Viral RNAIBA
01/2019 - 10/2002
10MIV 150IBA
12/2017 - 09/2008
10Anti-Infective Agents (Microbicides)IBA
02/2014 - 04/2009
9AntibodiesIBA
01/2021 - 02/2003
8Broadly Neutralizing AntibodiesIBA
01/2022 - 08/2015
8EpitopesIBA
01/2022 - 10/2002
8Monoclonal AntibodiesIBA
01/2020 - 03/2013
8Viral DNAIBA
01/2020 - 10/2002
7AIDS VaccinesIBA
01/2021 - 06/2005
7CarrageenanIBA
01/2018 - 11/2012
7Zinc AcetateFDA Link
12/2017 - 01/2011
7Glycoproteins (Glycoprotein)IBA
01/2016 - 02/2004
6Interleukin-15 (Interleukin 15)IBA
12/2019 - 06/2006
6AntigensIBA
11/2019 - 07/2004
5Neutralizing AntibodiesIBA
01/2021 - 02/2003
5CytokinesIBA
01/2019 - 04/2009
5SAIDS VaccinesIBA
01/2017 - 07/2005
4Bone Marrow Stromal Antigen 2IBA
01/2020 - 12/2013
4Reverse Transcriptase InhibitorsIBA
02/2014 - 11/2009
3Immunoglobulin G (IgG)IBA
12/2019 - 02/2013
3Pharmaceutical PreparationsIBA
01/2019 - 01/2014
3env Gene ProductsIBA
01/2018 - 10/2014
3ChemokinesIBA
11/2016 - 04/2009
3Complement System Proteins (Complement)IBA
11/2014 - 01/2011
3RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2014 - 11/2012
2N,N'- (2,2'- (hexa- 2,4- diyne- 1,6- diylbis(oxy))bis(2,3- dihydro- 1H- indene- 2,1- diyl))bis(1- (2- cyclohexyl- 2- (2- (methylamino)propanamido)acetyl)pyrrolidine- 2- carboxamide)IBA
02/2021 - 10/2020
2IgG Receptors (Fc gamma RI)IBA
01/2020 - 04/2010
2Immunoglobulins (Immunoglobulin)IBA
12/2018 - 05/2016
2CD40 Ligand (CD40L)IBA
11/2016 - 02/2004
2Histone Deacetylase InhibitorsIBA
12/2015 - 11/2014
2HLA-B Antigens (HLA-B)IBA
11/2015 - 11/2007
2Interferon Type IIBA
07/2014 - 04/2008
2Interferon-alpha (Interferon Alfa)IBA
12/2013 - 04/2008
2IntegrinsIBA
09/2013 - 06/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 03/2005
2Interleukin-10 (Interleukin 10)IBA
03/2013 - 08/2008
2HIV Reverse TranscriptaseIBA
09/2012 - 09/2008
2NucleosidesIBA
09/2012 - 11/2009
2CollagenIBA
03/2011 - 02/2007
2Viral ProteinsIBA
10/2010 - 08/2005
2OligodeoxyribonucleotidesIBA
04/2004 - 05/2003
1Amino AcidsFDA Link
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1pembrolizumabIBA
01/2022
1HIV AntigensIBA
01/2021
1Viral AntigensIBA
11/2020
1ProteomeIBA
11/2020
1Rubella VaccineIBA
01/2020
1DNA VaccinesIBA
01/2020
1Ribosomal DNA (rDNA)IBA
01/2019
1vesatolimodIBA
01/2019
1Griffithsia griffithsin proteinIBA
01/2018
1Minocycline (Cyclops)FDA LinkGeneric
01/2018
1Levonorgestrel (Plan B)FDA LinkGeneric
12/2017
1Contraceptive Agents (Contraceptives)IBA
12/2017
1HLA-DR Antigens (HLA-DR)IBA
07/2017
1BCG VaccineFDA Link
01/2017
1Interleukin-18 (Interleukin 18)IBA
11/2016
1Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2016
1Immunologic Factors (Immunomodulators)IBA
11/2016
1Interferon-gamma (Interferon, gamma)IBA
11/2016
1Biomarkers (Surrogate Marker)IBA
11/2016
1Interleukin-6 (Interleukin 6)IBA
11/2016

Therapy/Procedure

21Therapeutics
01/2022 - 11/2003
11Art Therapy
09/2021 - 11/2007
10Highly Active Antiretroviral Therapy (HAART)
12/2019 - 11/2009
4Immunotherapy
01/2020 - 02/2009
3Aftercare (After-Treatment)
01/2022 - 01/2016
2Drug Therapy (Chemotherapy)
01/2022 - 01/2017
1Intravenous Administration
01/2022
1Duration of Therapy
12/2019
1Treatment Delay
12/2019